Unknown

Dataset Information

Exercise intervention decreases acute and late doxorubicin-induced cardiotoxicity.


ABSTRACT:

Background

Doxorubicin (Dox) is one of the most effective chemotherapy agents used to treat adolescent and young adult sarcoma patients. Unfortunately, Dox causes cardiotoxicities that compromise long-term survival. We investigated whether exercise prevented cardiotoxicity and increased survival following myocardial infarction.

Methods

Juvenile mice received Dox, Dox + exercise (Exer), Dox then exercise or were exercised during and after Dox. Mice were evaluated by echocardiography and histology immediately after therapy and 12 weeks later. Mice subjected to permanent ligation of the left anterior descending artery 90 days after therapy were assessed for survival at 45 and 100 days.

Results

Mice treated with Dox, but not Dox + Exer, had decreased ejection fraction (EF

SUBMITTER: Wang F 

PROVIDER: S-EPMC8559466 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature